Multidiagnostic platform for Alzheimer’s disease

Development of a multi-diagnostic platform combining extraction, immunoassay and real-time PCR.


Combination of an enrichment process for diagnostically relevant biomarkers in blood samples from patients.


Improvement of the detection limit of immunological test methods for Alzheimer's related biomarkers. 

Joint Project

Roboscreen GmbH, Imk Health Intelligence GmbH and EDC Engineering GmbH develop and evaluatea multidiagnostic platform combining enrichment methods as well as improvement of biomarker detection and quantification of Alzheimer's related biomarkers in blood/serum/plasma and urine.

Funded Project

Funded Project No. 100690291


Started in October 2023.